Skip to content

Clinical trials

Pulmonary Disease, Chronic Obstructive trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Disease, Chronic Obstructive Country / region: Australia Clear all

137 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20021
20033
20042
20053
20067
20076
20089
20099
20108
20119
20125
20137
201410
20157
20166
20174
20181
20194
20205
20214
20223
20236
20244
20259
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed103
Recruiting11
Terminated10
Unknown status6
Active, not recruiting5
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline27
AstraZeneca19
Boehringer Ingelheim15
Novartis Pharmaceuticals9
Pearl Therapeutics, Inc.6
Pfizer5
Bayside Health3
Novartis3
Sanofi3
Broncus Technologies2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Disease, Chronic Obstructive137
Asthma10
Emphysema9
Lung Diseases6
Bronchitis, Chronic5
Dyspnea4
Lung Diseases, Obstructive4
Bronchiolitis Obliterans Syndrome2
Bronchitis2
Cardiovascular Diseases2

Trials

Showing 51 to 75 of 137. Each trial links to its page on Pharma Observatory.

37 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.